Grifor

Russian virosomal split vaccine against influenza, represented by mix of highly purified protective external and internal antigens of influenza A (H1N1 and H3N2) and B viruses; in phase I clinical trial 1/2009

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Viral Vaccines: 462
      - Influenza Vaccines: 6582
        Grifor: 2

Experts

1.	Korovkin, S A: 2 articles (03/2010 - 01/2009)
2.	Mel'nikov, S Ia: 2 articles (03/2010 - 01/2009)
3.	Drinevskiĭ, V P: 1 article (03/2010)
4.	Erman, E S: 1 article (03/2010)
5.	Erofeeva, M K: 1 article (03/2010)
6.	Gonchar, V V: 1 article (03/2010)
7.	Maksakova, V L: 1 article (03/2010)
8.	Nikonorov, I Iu: 1 article (03/2010)
9.	Pozdeev, V K: 1 article (03/2010)
10.	Semchenko, A V: 1 article (03/2010)

Related Diseases

1.	Human Influenza (Influenza) 01/01/2009 - "New Russian virosomal split vaccine against influenza "Grifor" was developed. " 03/01/2010 - "Reactogenicity, safety, and immunogenicity of Grifor vaccine compared with Vaxigrip vaccine was evaluated during phase III clinical trial in the Institute of Influenza. "

Related Drugs and Biologics

1.	Vaccines
2.	vaxigrip